Long-term safety and efficacy of imatinib in pulmonary arterial hypertension

被引：0
|
作者：
Hoeper, Marius [1 ]
Barst, Robyn [2 ]
Galie, Nazzareno [3 ]
Hassoun, Paul [4 ]
Morrell, Nicholas [5 ,6 ]
Peacock, Andrew [7 ]
Simonneau, Gerald [8 ]
Tapson, Victor [9 ]
Torres, Fernando [10 ]
Lawrence, David [11 ]
Quinn, Deborah [12 ]
Ghofrani, Hossein Ardeschir [13 ]
机构：
[1] Med Hsch, Resp Med, Hannover, Germany
[2] Columbia Univ, Resp Med, New York, NY USA
[3] Azienda Osped Univ Bologna, Resp Med, Bologna, Italy
[4] Johns Hopkins Univ, Resp Med, Baltimore, MD USA
[5] Addenbrookes Hosp, Resp Med, Cambridge, England
[6] Papworth Hosp, Resp Med, Cambridge, England
[7] Golden Jubilee Natl Hosp, Resp Med, Glasgow, Lanark, Scotland
[8] Univ Paris Sud XI, Resp Med, Orsay, France
[9] Duke Univ, Med Ctr, Resp Med, Durham, NC USA
[10] UT Southwestern Med Ctr, Resp Med, Dallas, TX USA
[11] Novartis Horsham Res Ctr, Resp Med, Horsham, W Sussex, England
[12] Novartis Pharmaceut, Resp Med, Cambridge, MA USA
[13] Univ Hosp Giessen & Marburg GmbH, Resp Med, Giessen, Germany
来源：
EUROPEAN RESPIRATORY JOURNAL | 2012年 / 40卷
关键词：
Pulmonary hypertension; Treatments;
D O I：
暂无
中图分类号：
R56 [呼吸系及胸部疾病];
学科分类号：
摘要：
3488
引用
收藏
页数：2
相关论文
共 50 条
  • [1] Long-term safety of a new formulation of epoprostenol in pulmonary arterial hypertension
    Delcroix, Marion
    Simonneau, Gerald
    Bergot, Emmanuel
    Boonstra, Anco
    Granton, John
    Langleben, David
    Subias, Pilar Escribano
    Galie, Nazzareno
    Pfister, Thomas
    Lemarie, Jean-Christophe
    Sitbon, Olivier
    EUROPEAN RESPIRATORY JOURNAL, 2013, 42
  • [2] Withdrawal of long-term epoprostenol therapy in pulmonary arterial hypertension (PAH)
    Calcaianu, George
    Chaouat, Ari
    Canuet, Matthieu
    Kessler, Romain
    EUROPEAN RESPIRATORY JOURNAL, 2015, 46
  • [3] Long-Term Outcomes With Ambrisentan Monotherapy in Pulmonary Arterial Hypertension
    Blalock, Shannon E.
    Matulevicius, Susan
    Mitchell, Laura C.
    Reimold, Sharon
    Warner, John
    Peshock, Ronald
    Torres, Fernando
    Chin, Kelly M.
    JOURNAL OF CARDIAC FAILURE, 2010, 16 (02) : 121 - 127
  • [4] Successful withdrawal of long-term epoprostenol therapy for pulmonary arterial hypertension
    Kim, NH
    Channick, RN
    Rubin, LJ
    CHEST, 2003, 124 (04) : 1612 - 1615
  • [5] Safety and Efficacy of Ambrisentan in the Treatment of Pulmonary Arterial Hypertension
    Valerio, Christopher J.
    Kabunga, Peter
    Coghlan, John G.
    CLINICAL MEDICINE INSIGHTS-THERAPEUTICS, 2009, 1 : 541 - 556
  • [6] Long-term efficacy of bosentan in inoperable chronic thromboembolic pulmonary hypertension
    M. C. Post
    H. W. M. Plokker
    J. C. Kelder
    R. J. Snijder
    Netherlands Heart Journal, 2009, 17 : 329 - 333
  • [7] Long-term efficacy of bosentan in inoperable chronic thromboembolic pulmonary hypertension
    Post, M. C.
    Plokker, H. W. M.
    Kelder, J. C.
    Snijder, R. J.
    NETHERLANDS HEART JOURNAL, 2009, 17 (09): : 329 - 333
  • [8] REPAIR: long-term effects of macitentan on the right ventricle (RV) in pulmonary arterial hypertension (PAH)
    Kiely, David
    Cottreel, Emmanuelle
    Galie, Nazzareno
    Marcus, J. Tim
    Peacock, Andrew
    Rosenkranz, Stephan
    Swift, Andrew J.
    Tawakol, Ahmed
    Torbicki, Adam
    Noordegraaf, Anton Vonk
    Wetherill, Graham
    Channick, Richard
    EUROPEAN RESPIRATORY JOURNAL, 2020, 56
  • [9] Long-term inhaled nitric oxide plus dipyridamole for pulmonary arterial hypertension
    Pérez-Peñate, G
    Navarro, PC
    González, MP
    Gómez, EG
    Duque, JP
    Quintana, AG
    Serdá, GJ
    RESPIRATION, 2005, 72 (04) : 419 - 422
  • [10] Acute and Long-Term Efficacy and Safety of Sildenafil for the Treatment of Chronic Thromboembolic Pulmonary Hypertension in a Heart Transplant Recipient
    Zaca, Valerio
    Padeletti, Margherita
    Pagliaro, Antonio
    Furiozzi, Fabio
    Mondillo, Sergio
    Favilli, Roberto
    PHARMACOLOGY, 2011, 87 (1-2) : 24 - 27
12345